Associations between dopamine D2 receptor availability and BMI depend on age

OBJECTIVE The dopamine D2/3 receptor subtypes (DRD2/3) are the most widely studied neurotransmitter biomarker in research on obesity, but results to date have been inconsistent, have typically involved small samples, and have rarely accounted for subjects' ages despite the large impact of age on DRD2/3 levels. We aimed to clarify the relation between DRD2/3 availability and BMI by examining this association in a large sample of subjects with BMI spanning the continuum from underweight to extremely obese. SUBJECTS 130 healthy subjects between 18 and 81years old underwent PET with [18F]fallypride, a high affinity DRD2/3 ligand. RESULTS As expected, DRD2/3 availability declined with age. Critically, age significantly interacted with DRD2/3 availability in predicting BMI in the midbrain and striatal regions (caudate, putamen, and ventral striatum). Among subjects under 30years old, BMI was not associated with DRD2/3 availability. By contrast, among subjects over 30years old, BMI was positively associated with DRD2/3 availability in the midbrain, putamen, and ventral striatum. CONCLUSION The present results are incompatible with the prominent dopaminergic hypofunction hypothesis that proposes that a reduction in DRD2/3 availability is associated with increased BMI, and highlights the importance of age in assessing correlates of DRD2/3 function.

[1]  Pradeep J Nathan,et al.  Small effect of dopamine release and no effect of dopamine depletion on [18F]fallypride binding in healthy humans , 2007, Synapse.

[2]  E. Molinari,et al.  D2 dopamine receptor (DRD2) gene Taq1A polymorphism and the eatingrelated psychological traits in eating disorders (anorexia nervosa and bulimia) and obesity , 2007, Eating and weight disorders : EWD.

[3]  M. Meguid,et al.  LHA dopaminergic activity in obese and lean Zucker rats , 1995, Neuroreport.

[4]  J. Critchley,et al.  An affected pedigree member analysis of linkage between the dopamine D2 receptor gene TaqI polymorphism and obesity and hypertension. , 2005, International journal of cardiology.

[5]  Paul Cumming,et al.  Parametric mapping of binding in human brain of D2 receptor ligands of different affinities. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[6]  Christopher I. Amos,et al.  Variant alleles of the D2 dopamine receptor gene and obesity , 2000 .

[7]  P. Kenny,et al.  Dopamine D2 receptors in addiction-like reward dysfunction and compulsive eating in obese rats , 2010, Nature Neuroscience.

[8]  A. Hajnal,et al.  Altered basal and stimulated accumbens dopamine release in obese OLETF rats as a function of age and diabetic status. , 2007, American journal of physiology. Regulatory, integrative and comparative physiology.

[9]  William J. Jagust,et al.  Genetic effects on behavior are mediated by neurotransmitters and large-scale neural networks , 2013, NeuroImage.

[10]  Mark Slifstein,et al.  Striatal and extrastriatal dopamine release measured with PET and [18F] fallypride , 2010, Synapse.

[11]  C. Breitenstein,et al.  Compensatory weight gain due to dopaminergic hypofunction: new evidence and own incidental observations , 2008, Nutrition & metabolism.

[12]  K. Black,et al.  A comparison of D2 receptor specific binding in obese and normal‐weight individuals using PET with (N‐[11C]methyl)benperidol , 2013, Synapse.

[13]  E. Mariman,et al.  Extreme obesity is associated with variation in genes related to the circadian rhythm of food intake and hypothalamic signaling. , 2015, Physiological genomics.

[14]  Semi Helin,et al.  Effects of intravenous glucose on dopaminergic function in the human brain in vivo , 2007, Synapse.

[15]  T. Yarkoni.  Big Correlations in Little Studies: Inflated fMRI Correlations Reflect Low Statistical Power—Commentary on Vul et al. (2009) , 2009, Perspectives on psychological science : a journal of the Association for Psychological Science.

[16]  W. K. Simmons,et al.  Striatal dopamine D2-like receptor correlation patterns with human obesity and opportunistic eating behavior , 2014, Molecular Psychiatry.

[17]  K. Flegal,et al.  Prevalence of childhood and adult obesity in the United States, 2011-2012. , 2014, JAMA.

[18]  T. van Amelsvoort,et al.  Lower striatal dopamine D2/3 receptor availability in obese compared with non-obese subjects , 2011, EJNMMI research.

[19]  William J Jagust,et al.  Dopamine Supports Coupling of Attention-Related Networks , 2012, The Journal of Neuroscience.

[20]  Carolyn C. Meltzer,et al.  Increased Dopamine D2/D3 Receptor Binding After Recovery from Anorexia Nervosa Measured by Positron Emission Tomography and [11C]Raclopride , 2005, Biological Psychiatry.

[21]  Lauri Tuominen,et al.  Obesity Is Associated with Decreased μ-Opioid But Unaltered Dopamine D2 Receptor Availability in the Brain , 2015, Journal of Neuroscience.

[22]  A. Meyer-Lindenberg,et al.  Age-related changes in midbrain dopaminergic regulation of the human reward system , 2008, Proceedings of the National Academy of Sciences.

[23]  P. Fletcher,et al.  Obesity and the brain: how convincing is the addiction model? , 2012, Nature Reviews Neuroscience.

[24]  Thomas J. H. Chen,et al.  Increased prevalence of the Taq I A1 allele of the dopamine receptor gene (DRD2) in obesity with comorbid substance use disorder: a preliminary report. , 1996, Pharmacogenetics.

[25]  M. K. Das,et al.  Fluorinated benzamide neuroleptics--III. Development of (S)-N-[(1-allyl-2-pyrrolidinyl)methyl]-5-(3-[18F]fluoropropyl)-2, 3-dimethoxybenzamide as an improved dopamine D-2 receptor tracer. , 1995, Nuclear medicine and biology.

[26]  L. Nyberg,et al.  The correlative triad among aging, dopamine, and cognition: Current status and future prospects , 2006, Neuroscience & Biobehavioral Reviews.

[27]  D. Grandy,et al.  D2 dopamine receptor gene and obesity. , 1994, The International journal of eating disorders.

[28]  F. Yasuno,et al.  Relation among dopamine D2 receptor binding, obesity and personality in normal human subjects , 2001, Neuroscience Letters.

[29]  Yu-Shin Ding,et al.  Low dopamine striatal D2 receptors are associated with prefrontal metabolism in obese subjects: Possible contributing factors , 2008, NeuroImage.

[30]  M. First,et al.  Structured Clinical Interview for DSM-IV Axis I Disorders , 1997 .

[31]  J. Lammertyn,et al.  How is reward sensitivity related to bodyweight in children? , 2012, Appetite.

[32]  K. Cosgrove,et al.  Opposing relationships of BMI with BOLD and dopamine D2/3 receptor binding potential in the dorsal striatum , 2015, Synapse.

[33]  James Robert Brašić,et al.  Alterations of Central Dopamine Receptors Before and After Gastric Bypass Surgery , 2010, Obesity surgery.

[34]  Jonathan M. Koller,et al.  Insulin, Central Dopamine D2 Receptors, and Monetary Reward Discounting in Obesity , 2015, PloS one.

[35]  Alan A. Wilson,et al.  Ventral Striatum Binding of a Dopamine D2/3 Receptor Agonist But Not Antagonist Predicts Normal Body Mass Index , 2015, Biological Psychiatry.

[36]  Mark Slifstein,et al.  In vivo affinity of [18F]fallypride for striatal and extrastriatal dopamine D2 receptors in nonhuman primates , 2004, Psychopharmacology.

[37]  C Bogardus,et al.  Association of dopamine D2 receptor polymorphisms Ser311Cys and TaqIA with obesity or type 2 diabetes mellitus in Pima Indians , 2000, International Journal of Obesity.

[38]  J. Palacios,et al.  Dopamine receptors in human brain: Autoradiographic distribution of D2 sites , 1989, Neuroscience.

[39]  Gabrielle Turner-McGrievy,et al.  D2 dopamine receptor Taq1A polymorphism, body weight, and dietary intake in type 2 diabetes. , 2009, Nutrition.

[40]  Haomiao Jia,et al.  Trends in quality-adjusted life-years lost contributed by smoking and obesity. , 2010, American journal of preventive medicine.

[41]  J. Mennella,et al.  Habituation to the pleasure elicited by sweetness in lean and obese women , 2012, Appetite.

[42]  Osama Mawlawi,et al.  Imaging Human Mesolimbic Dopamine Transmission with Positron Emission Tomography: I. Accuracy and Precision of D2 Receptor Parameter Measurements in Ventral Striatum , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[43]  N. Volkow,et al.  Relationship of Dopamine Type 2 Receptor Binding Potential With Fasting Neuroendocrine Hormones and Insulin Sensitivity in Human Obesity , 2012, Diabetes Care.

[44]  H. Heinze,et al.  Mesolimbic Functional Magnetic Resonance Imaging Activations during Reward Anticipation Correlate with Reward-Related Ventral Striatal Dopamine Release , 2008, The Journal of Neuroscience.

[45]  Jean Logan,et al.  Brain dopamine and obesity , 2001, The Lancet.

[46]  Xu-Feng Huang,et al.  High-Fat Diet Exposure Increases Dopamine D2 Receptor and Decreases Dopamine Transporter Receptor Binding Density in the Nucleus Accumbens and Caudate Putamen of Mice , 2008, Neurochemical Research.